Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-07-30 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200730 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2020) and disposed of shares related to employee incentive plans. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement ('gereglementeerde informatie') detailing specific dates, quantities, and prices of these transactions, making it a specific filing rather than a general regulatory announcement (RNS) or a report publication announcement (RPA).
2020-07-30 Dutch
200730 - Transparency notification press release FMR LLC .pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparency notification' from FMR LLC to UCB SA/NV, dated July 30, 2020, regarding a change in shareholding that crossed the 3% threshold on July 27, 2020. This type of filing, which reports personal share transactions by executives or significant shareholders crossing regulatory ownership thresholds, directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the core content is the notification of crossing a major shareholding threshold (3%) and detailing the exact number of shares held by the entity and its affiliates, 'Major Shareholding Notification' (MRQ) is the most precise fit. It is not a Director's Dealing (DIRS) as it concerns an institutional investor (FMR LLC) crossing a public disclosure threshold, rather than a director's personal trade.
2020-07-30 English
200730 - Notification de transparence comm. de presse FMR LLC .pdf
Director's Dealing Classification · 1% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) from FMR LLC to UCB SA, announcing that a related entity crossed the 3% threshold of voting rights on July 27, 2020. This type of filing, which reports changes in significant share ownership or voting rights crossing regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS category.
2020-07-30 French
200730 - Transparantieverklaring persbericht FMR LLC .pdf
Director's Dealing Classification · 1% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) issued in Brussels, Belgium, concerning a change in shareholding that crossed the 3% threshold, as mandated by Belgian law ('wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen'). This type of filing reports personal share transactions by major shareholders or entities, which directly corresponds to the definition of Director's Dealing or Insider Trading reports, although here it is a major shareholder notification. Reviewing the provided codes, 'DIRS' (Director's Dealing) covers personal share transactions by directors and executives. While this specific filing concerns a major institutional shareholder (FMR LLC/Fidelity), the core subject is the notification of a change in significant ownership/voting rights crossing a regulatory threshold. The closest fit among the provided specific codes is 'MRQ' (Major Shareholding Notification), which covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The document explicitly details the previous and current share counts and percentages, confirming it is a major shareholding notification.
2020-07-30 Dutch
2020 HY report - mgt report - EN.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled '2020 half-year financial report' and contains comprehensive financial statements, including income statements, balance sheets, cash flow statements, and notes to the accounts for the six-month period ending 30 June 2020. It provides detailed financial analysis and performance reviews, fitting the definition of an Interim/Quarterly Report (IR). H1 2020
2020-07-27 English
2020 HY report - mgt report - FR.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Rapport de gestion du premier semestre 2020' (Management Report for the first half of 2020). It contains comprehensive financial statements, including consolidated income statements, balance sheets, cash flow statements, and detailed notes to the financial statements for the six-month period ending June 30, 2020. As it provides substantive financial data and analysis for an interim period, it is classified as an Interim/Quarterly Report. H1 2020
2020-07-27 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.